about
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several ne...
Read More
234.76
4.75
(2.07%)
7.2M
XNYS Volume
XNYS 23 Jun, 2026 5:30 PM (EDT)
Acquisition Talks
AbbVie reportedly nears a deal to buy Apogee Therapeutics for $10.9 bn to expand its drug pipeline
See details
Not Eligible
Expensive Valuation
Technically Neutral
AbbVie Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..